Search research articles
Contact Us
Filters
Showing results (541-550 of 686) with videos related to
Page
of 69
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
May 24, 2016
CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY
Vivian A Fonseca, George Grunberger, Henry Anhalt, et al.
Diabetes Care
|
August 6, 2016
Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial
Bo Ahrén, Irl B Hirsch, Thomas R Pieber, et al.
The American Journal of Managed Care
|
April 14, 2025
The role of advanced technologies in improving diabetes outcomes
David G Marrero, Christopher G Parkin, Grazia Aleppo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 25, 2025
Into the Unknown: Practical Remdesivir Restriction in the Era of Widespread SARS-CoV-2 Seropositivity
Alyssa Christensen, Zachary Nelson, Sally Gustafson, et al.
Diabetes Technology & Therapeutics
|
March 18, 2025
A 13-Week Single-Arm Evaluation of Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes
Roy W Beck, Ryan J Bailey, Halis K Akturk, et al.
Diabetes, Obesity & Metabolism
|
May 29, 2013
Options for prandial glucose management in type 2 diabetes patients using basal insulin: addition of a short-acting GLP-1 analogue versus progression to basal-bolus therapy
I B Hirsch, J B Buse, J Leahy, et al.
JAMA
|
January 25, 2017
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial
Marcus Lind, William Polonsky, Irl B Hirsch, et al.
Journal of Diabetes Science and Technology
|
April 10, 2025
Addressing the Diabetes Tsunami Requires Expanded Access to Diabetes Technologies
Davida F Kruger, Christopher G Parkin, Irl B Hirsch, et al.
Diabetes, Obesity & Metabolism
|
November 17, 2020
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5)
Arndís F Ólafsdóttir, Jan Bolinder, Tim Heise, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
March 2, 2011
Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring
Thomas C Blevins, Bruce W Bode, Satish K Garg, et al.
Page
of 69
Search research articles
Search
Showing results (541-550 of 686) with videos related to
Sort By:
Page
of 69
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
May 24, 2016
CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY
Vivian A Fonseca, George Grunberger, Henry Anhalt, et al.
Diabetes Care
|
August 6, 2016
Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial
Bo Ahrén, Irl B Hirsch, Thomas R Pieber, et al.
The American Journal of Managed Care
|
April 14, 2025
The role of advanced technologies in improving diabetes outcomes
David G Marrero, Christopher G Parkin, Grazia Aleppo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 25, 2025
Into the Unknown: Practical Remdesivir Restriction in the Era of Widespread SARS-CoV-2 Seropositivity
Alyssa Christensen, Zachary Nelson, Sally Gustafson, et al.
Diabetes Technology & Therapeutics
|
March 18, 2025
A 13-Week Single-Arm Evaluation of Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes
Roy W Beck, Ryan J Bailey, Halis K Akturk, et al.
Diabetes, Obesity & Metabolism
|
May 29, 2013
Options for prandial glucose management in type 2 diabetes patients using basal insulin: addition of a short-acting GLP-1 analogue versus progression to basal-bolus therapy
I B Hirsch, J B Buse, J Leahy, et al.
JAMA
|
January 25, 2017
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial
Marcus Lind, William Polonsky, Irl B Hirsch, et al.
Journal of Diabetes Science and Technology
|
April 10, 2025
Addressing the Diabetes Tsunami Requires Expanded Access to Diabetes Technologies
Davida F Kruger, Christopher G Parkin, Irl B Hirsch, et al.
Diabetes, Obesity & Metabolism
|
November 17, 2020
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5)
Arndís F Ólafsdóttir, Jan Bolinder, Tim Heise, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
March 2, 2011
Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring
Thomas C Blevins, Bruce W Bode, Satish K Garg, et al.
Page
of 69